Bruin Biometrics said it has landed FDA de novo clearance for its SEM Scanner, a wireless, handheld device to help assess patients at increased risk for pressure ulcers.
The scanner is a novel device that can objectively alert clinicians to specific anatomical areas of a patient’s body at increased risk for developing pressure damage before that damage is visible at the skin surface. Pressure sores typically appear at areas of bony prominence, such as the heels and sacrum.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.